36 -9 (71) 2024 - Oblokulova Z.I., Vakhobov A.A. - EXTRAHEPATIC MANIFESTATIONS OF CHRONIC VIRAL HEPATITIS C

EXTRAHEPATIC MANIFESTATIONS OF CHRONIC VIRAL HEPATITIS C

Oblokulova Z.I. - Bukhara State Medical Institute named after Abu Ali ibn Sino

Vakhobov A.A. - Bukhara Regional Hospital of Infectious Diseases

Resume

The purpose of the study. A retrospective analysis of 319 adult patients aged 18 to 71 years with HCV caused by HCV genotypes 1, 2, 3 who were treated at the Bukhara OIB in the period from 2018 to 2020 was carried out. The main group of patients with fibrotic processes of the F2-F3 stage was 74.1%, and the control group of patients with the F1–F2 stage of fibrotic lesion was 63.8%. Fibrotic lesions of the F0 – F1 stage in the main group amounted to 21.4%, and in the control group 47.9% of cases. Cryoglobulinemic vasculitis was observed in 34.8% of cases, among its manifestations: arthritis 28.2%, hemorrhagic vasculitis 46.2%, peripheral neuropathy 15.4%, chronic glomerulonephritis 5.1%. 2 cases of B-cell lymphoma have been reported in female patients at the stage of liver cirrhosis.

Key words: chronic hepatitis C, extrahepatic manifestations, cryoglobulinemic vasculitis, hemorrhagic vasculitis, liver fibrosis.

First page

182

Last page

186

For citation:Oblokulova Z.I., Vakhobov A.A. - EXTRAHEPATIC MANIFESTATIONS OF CHRONIC VIRAL HEPATITIS C//New Day in Medicine 9(71)2024 182-186 https://newdayworldmedicine.com/en/new_day_medicine/9-71-2024

List of References

  1. Изранов В.А. Физические основы эластографии печени. //Вестн. Балт. фед. ун-та им. И. Канта. 2019;2:69-87.
  2. В.Т. Ивашкин, М.В. Маевская, Ч.С. Павлов Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени //Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(4):71-102.
  3. Кулебина Е.А., Сурков А.Н., Усольцева О.В. Неинвазивная диагностика фиброза печени: возможности инструментальных методик на современном этапе. //РМЖ. Медицинское обозрение. 2020;4(5):297-301.
  4. Пирогова И.Ю. С.А. Пышкин Диагностика фиброза печени: инвазивные и неинвазивные методы //Сиб. мед. журн. 2011;3:10-15.
  5. Рахимова В.Ш., Эгамова И.Н., Ярмухамедова Н.А. Суставной синдром как внепеченочные проявления хронического вирусного гепатита С //Проблемы биологии и медицины. 2020;2(118):99-101.
  6. Щекотова А.П., Невзорова М.С., Ермакова О.А. Современные методы лабораторной диагностики фиброза печени //Вестник науки и образования. 2018;17-2(53):6.
  7. Carrat F, Fontaine H, Dorival C. et all. French ANRS CO22 Hepathercohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. //Lancet. 2019;393:1453-1464.
  8. Martinello M, Hajarizadeh B, Grebely J, Dore GJ, Matthews GV. Management of acute HCV infection in the era of direct-acting antiviral therapy. //Nat Rev Gastroenterol Hepatol. 2018;15:412-424.
  9. Midia M, Odedra D, Shuster A, Midia R, Muir J. Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review. //Diagn Interv Radiol. 2019;25(1):71-80. doi:10.5152/dir.2018.17525.
  10. Romano C, Cuomo G, Ferrara R, Del Mastro A, Esposito S, Sellitto A, Adinolfi LE. Uncommon immune-mediated extrahepatic manifestations of HCV infection. //Expert Rev Clin Immunol. 2018;14:1089-1099.

    file

    download